Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study

COVID ‐19 vaccines and risks of hematological abnormalities: Nested case–control and self‐controlled case series study

(2022) Chor‐Wing Sing et al.   AMERICAN JOURNAL OF HEMATOLOGY

Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine

(2022) Francisco Tsz Tsun Lai et al.   ANNALS OF INTERNAL MEDICINE

Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study

(2022) Xue Li et al.   GUT

Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong

(2022) Francisco Tsz Tsun Lai et al.   Nature Communications

Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study

(2022) Xi Xiong et al.   THYROID

Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong

(2022) Xue Li et al.   JAMA Pediatrics

Myocarditis With COVID-19 mRNA Vaccines

(2021) Biykem Bozkurt et al.   CIRCULATION

Myocarditis and Pericarditis After Vaccination for COVID-19

(2021) George A. Diaz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

(2021) Noam Barda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study

(2021) Julia Hippisley-Cox et al.   BMJ-British Medical Journal

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

(2021) Hannah G. Rosenblum et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021

(2021) Anne M. Hause et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

(2021) Julia W. Gargano et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines

(2021) David K. Shay et al.   JAMA Cardiology

Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination

(2021) Gilbert T Chua et al.   CLINICAL INFECTIOUS DISEASES

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

(2021) Guy Witberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study

(2021) Anders Husby et al.   BMJ-British Medical Journal

Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units

(2020) Lara S. Shekerdemian et al.   JAMA Pediatrics

Disease and healthcare burden of COVID-19 in the United States

(2020) Ian F. Miller et al.   NATURE MEDICINE

Should We Mandate a COVID-19 Vaccine for Children?

(2020) Douglas J. Opel et al.   JAMA Pediatrics

Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis

(2018) Tomi O. Sarkanen et al.   SLEEP MEDICINE REVIEWS

Effects of race and ethnicity on the incidence of venous thromboembolism

(2009) Richard H. White et al.   THROMBOSIS RESEARCH

Redistribution or horizontal equity in Hong Kong's mixed public-private health system: a policy conundrum

(2008) Gabriel M. Leung et al.   HEALTH ECONOMICS